Skip to content
OpenCapital
Get started

Haemonetics HAE Q4 2026 Annual earnings

Reported May 7, 2026 · Before market open

Revenue$346.4MBeat by $9.5M
EPS$1.29Beat by $0.01
Revenue estimate$336.8M
EPS estimate$1.28

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$327.9M
EPS estimate$1.07

Financials

Q4 2026

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$3.63B+1.2%
Enterprise value$4.66B+3.1%
P/S2.7×+0.1×

Profitability

See full
Gross margin59%+4.0pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Debt / equity1.6×0.0×
Current ratio3×+1.3×

Segments

By segment

See full
Hospital$159.6M+8.0%
Plasma$130.3M+2.8%
Blood Center$56.4M+0.7%

By geography

See full
Europe$52.9M+25.1%
Rest of Asia$20.0M-5.6%
Other$3.1M+12.3%

By product

See full
Plasma$130.3M+2.8%

Versus estimates

Revenue

Q4 2026$346.4MBeat by $9.5M
Q3 2026$339.0MBeat by $7.1MQ2 2026$327.3MMiss by $2.5MQ1 2026$321.4MBeat by $1.4MQ4 2025$330.6MBeat by $18.1MQ3 2025$348.5MMiss by $5.9M

Diluted EPS

Q4 2026$1.29Beat by $0.01
Q3 2026$1.31Beat by $0.04Q2 2026$1.27Beat by $0.15Q1 2026$1.10Beat by $0.09Q4 2025$1.24Beat by $0.02Q3 2025$1.19Beat by $0.01

Ask the moment Haemonetics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Haemonetics report Q4 2026 earnings?
Haemonetics (HAE) reported Q4 2026 earnings on May 7, 2026 before market open.
What were Haemonetics's Q4 2026 revenue and EPS?
Haemonetics reported revenue of $346.4M and eps of $1.29 for Q4 2026.
Did Haemonetics beat estimates in Q4 2026?
Revenue beat the consensus estimate of $336.8M by $9.5M. EPS beat the consensus estimate of $1.28 by $0.01.
How did Haemonetics's Q4 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 4.8% from $330.6M a year earlier and eps grew 4.0% from $1.24.
Where can I find Haemonetics's Q4 2026 SEC filings?
You can read the 8-K earnings release (0000313143-26-000031) and the 10-K periodic report (0000313143-26-000050) directly on SEC EDGAR. The filing index links above go to sec.gov.